Centene Corp has dropped over 40%, and Adhishthana principles suggest that the decline signals deeper structural issues.

The 25% decline in Centene’s stock seems warranted given the substantial earnings adjustment and ongoing ambiguity. With more state data still forthcoming and the threat of additional earnings ...

Centene is set to announce its second-quarter results later this month, and analysts anticipate double-digit earnings drop.

CNBC’s Jim Cramer gave his take Centene and the broader health insurance space after shares plummeted on Wednesday.

The S&P 500 added 0.5% on Thursday, July 17, 2025, notching a record closing high for the first time in a week as June retail ...

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning.

The Clayton-based health giant is likely to face increased challenges as federal government tightens Medicaid eligibility and ...

Shares of Centene are experiencing a historic collapse this week. Wednesday marked the worst single-day performance in the company's history.

On this news, Centene's stock price fell $22.87, or 40.4%, to close at $33.78 per share on July 2, 2025, thereby injuring invetors. What Is The Lawsuit About?

U.S. equities mostly gained at midday on a new U.S.-Vietnam trade agreement, although the advance was limited by a decline in ...

CNBC's Jim Cramer offered his take on healthcare company Centene and explained why he thinks the stock plummeted on Wednesday, telling investors to stay away from the sector as a whole.